03:40 PM EDT, 03/12/2024 (MT Newswires) -- Health care stocks rose late Tuesday afternoon, with the NYSE Health Care Index increasing 0.7% and the Health Care Select Sector SPDR Fund (XLV) gaining 0.6%.

The iShares Biotechnology ETF (IBB) fell 0.5%.

In corporate news, Geron's ( GERN ) imetelstat will be reviewed by the US Food and Drug Administration's Oncology Drugs Advisory Committee on Thursday, and the panel will discuss if the drug's benefits outweigh the risks, according to documents released ahead of the meeting. Geron ( GERN ) shares tumbled 15%.